Position in REGN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$776,930
-$32,796 QoQ
Shares Held
1,246
+18.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#704
of 1,328 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Frec Markets, Inc. holds $8,586,783 across 18 Biotechnology names. REGN ranks #5 (9.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,778 | $1,379,915 | |
| 2 | INCY |
Incyte Corp
|
10,592 | $1,200,709 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
20,555 | $1,176,157 | |
| 4 | EXEL |
Exelixis, Inc.
|
14,365 | $781,599 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
1,246 | $776,930 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,618 | $487,066 | |
| 7 | RPRX |
Royalty Pharma plc
|
6,504 | $364,679 | |
| 8 | MRNA |
Moderna, Inc.
|
5,100 | $357,153 |
All Filings in REGN
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $776,930 | 1,246 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $809,726 | 1,048 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $381,303 | 494 | Shares | Defined | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||